Implementation strategies to increase smoking cessation treatment provision in primary care: a systematic review of observational studies
Tóm tắt
Internationally, there is an ‘evidence-practice gap’ in the rate healthcare professionals assess tobacco use and offer cessation support in clinical practice, including primary care. Evidence is needed for implementation strategies enacted in the ‘real-world’. Aim: To identify implementation strategies aiming to increase smoking cessation treatment provision in primary care, their effectiveness, cost-effectiveness and any perceived facilitators and barriers for effectiveness.
‘Embase’, ‘Medline’, ‘PsycINFO’, ‘CINAHL’, ‘Global Health’, ‘Social Policy & Practice’, ‘ASSIA Applied Social Sciences Index and Abstracts’ databases, and grey literature sources were searched from inception to April 2021. Studies were included if they evaluated an implementation strategy implemented on a nation-/state-wide scale, targeting any type of healthcare professional within the primary care setting, aiming to increase smoking cessation treatment provision. Primary outcome measures: implementation strategy identification, and effectiveness (practitioner-/patient-level). Secondary outcome measures: perceived facilitators and barriers to effectiveness, and cost-effectiveness. Studies were assessed using the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool. A narrative synthesis was conducted using the Expert Recommendations for Implementing Change (ERIC) compilation and the Consolidated Framework for Implementation Research (CFIR).
Of 49 included papers, half were of moderate/low risk of bias. The implementation strategy domains identified involved utilizing financial strategies, changing infrastructure, training and educating stakeholders, and engaging consumers. The first three increased practitioner-level smoking status recording and cessation advice provision. Interventions in the utilizing financial strategies domain also appeared to increase smoking cessation (patient-level). Key facilitator: external policies/incentives (tobacco control measures and funding for public health and cessation clinics). Key barriers: time and financial constraints, lack of free cessation medications and follow-up, deprioritisation and unclear targets in primary care, lack of knowledge of healthcare professionals, and unclear messaging to patients about available cessation support options. No studies assessed cost-effectiveness.
Some implementation strategy categories increased the rate of smoking status recording and cessation advice provision in primary care. We found some evidence for interventions utilizing financial strategies having a beneficial impact on cessation. Identified barriers to effectiveness should be reduced. More pragmatic approaches are recommended, such as hybrid effectiveness-implementation designs and utilising Multiphase Optimization Strategy methodology.
PROSPERO:CRD42021246683
Từ khóa
Tài liệu tham khảo
Office for Health Improvement and Disparities. Smoking and tobacco: applying All Our Health. 2021. Available from: https://www.gov.uk/government/publications/smoking-and-tobacco-applying-all-our-health/smoking-and-tobacco-applying-all-our-health. [Cited 2022 Feb 23].
World Health Organisation (WHO). Tobacco Factsheet. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/tobacco. [Cited 2022 Feb 23].
Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting Smoking Among Adults — United States, 2000–2015. MMWR Morb Mortal Wkly Rep. 2017;65(52):1457–64.
Action on Smoking and Health (ASH). ASH and Breathe2025 response to Advancing our health: prevention in the 2020s. 2019. Available from: https://ash.org.uk/wp-content/uploads/2019/10/ASH_Breathe2025PGPconsubmissionFINAL.pdf.
Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of tobacco smoking: a review. JAMA. 2022;327(6):566–77.
National Institute for Health and Care Excellence (NICE). NICE guideline [NG209] - Tobacco: preventing uptake, promoting quitting and treating dependence. 2021. Available from: https://www.nice.org.uk/guidance/ng209. [Cited 2022 Feb 23].
West R, Papadakis S. Stop smoking services: increased chances of quitting. 2019. Available from: https://www.ncsct.co.uk/usr/pub/Stopsmokingserviceseffectiveness.pdf.
Manolios E, Sibeoni J, Teixeira M, Révah-Levy A, Verneuil L, Jovic L. When primary care providers and smokers meet: a systematic review and metasynthesis. NPJ Prim Care Respir Med. 2021;31(1):31.
World Health Organisation (WHO). WHO Report on the Global Tobacco Epidemic 2019: offer help to quit tobacco use. Geneva; 2019. Available from: https://www.who.int/teams/health-promotion/tobacco-control/who-report-on-the-global-tobacco-epidemic-2019.
World Health Organization (WHO). WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva; 2021. Available from: https://www.who.int/publications/i/item/9789240032095. [Cited 2022 Mar 10].
Cancer Research UK. Making conversations count. The health and economic benefits of improving smoking cessation support in UK general practice. London; 2020. Available from: https://www.cancerresearchuk.org/sites/default/files/cancer-stats/making_conversations_count_-_full_report_-_october_2020/making_conversations_count_-_full_report_-_october_2020.pdf.
Fiore M, Jaen C, Baker T. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD; 2008. Available from: https://www.ncbi.nlm.nih.gov/books/NBK63952/.
National Centre for Smoking Cessation and Training (NCSCT). Very Brief Advice training module. 2014. Available from: https://www.ncsct.co.uk/publication_very-brief-advice.php. [Cited 2021 May 18].
Bartsch AL, Härter M, Niedrich J, Brütt AL, Buchholz A. A Systematic Literature Review of Self-Reported Smoking Cessation Counseling by Primary Care Physicians. PLoS One. 2016;11(12):e0168482.
Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychol. 2015;3(1):32.
Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013;8(1):139.
Curran GM. Implementation science made too simple: a teaching tool. Implement Sci Commun. 2020;1(1):27.
Waltz TJ, Powell BJ, Matthieu MM, Damschroder LJ, Chinman MJ, Smith JL, et al. Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study. Implement Sci. 2015;10(1):109. https://doi.org/10.1186/s13012-015-0295-0.
Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10(1):21. https://doi.org/10.1186/s13012-015-0209-1.
Lindson N, Pritchard G, Hong B, Fanshawe TR, Pipe A, Papadakis S. Strategies to improve smoking cessation rates in primary care. Cochrane Database of Syst Rev. 2021;2021(9):CD011556. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011556.pub2/full
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372):n71.
Ewald H, Hirt J, Nordhausen T, Appenzeller-Herzog C. Using citation tracking for systematic literature searching - study protocol for a scoping review of methodological studies and a Delphi study. F1000Res. 2021;9:1386.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Mueller M, D’Addario M, Egger M, Cevallos M, Dekkers O, Mugglin C, et al. Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations. BMC Med Res Methodol. 2018;18(1):44.
Sterne JAC, Hernán MA, McAleenan A, Reeves BC, Higgins JPT. Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 62 (updated February 2021). 2021. Available from: https://training.cochrane.org/handbook. [Cited 2022 Feb 3].
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
Szatkowski L, Aveyard P. Provision of smoking cessation support in UK primary care: Impact of the 2012 QOF revision. Br J Gen Pract. 2016;66(642):e10–5.
Szatkowski L, McNeill A, Lewis S, Coleman T. A comparison of patient recall of smoking cessation advice with advice recorded in electronic medical records. BMC Public Health. 2011;11:291.
Szatkowski L, Lewis S, McNeill A, Coleman T. Is smoking status routinely recorded when patients register with a new GP? Fam Pract. 2010;27(6):673–5.
Taggar J, Coleman T, Lewis S, Szatkowski L. The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from The Health Improvement Network (THIN) database. BMC Public Health. 2012;12:329.
Alageel S, Gulliford MC. Health checks and cardiovascular risk factor values over six years’ follow-up: Matched cohort study using electronic health records in England. PLoS Med. 2019;16(7):1–16.
Coleman T, Lewis S, Hubbard R, Smith C. Impact of contractual financial incentives on the ascertainment and management of smoking in primary care. Addiction (Abingdon, England). 2007;102(5):803–8.
Szatkowski L, Coleman T, McNeill A, Lewis S. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England. Addiction (Abingdon, England). 2011;106(10):1827–34.
Langley TE, Huang Y, Lewis S, McNeill A, Coleman T, Szatkowski L. Prescribing of nicotine replacement therapy to adolescents in England. Addiction (Abingdon, England). 2011;106(8):1513–9.
Langley TE, Szatkowski L, McNeill A, Coleman T, Lewis S. Prescribing of nicotine replacement therapy to cardiovascular disease patients in England. Addiction (Abingdon, England). 2012;107(7):1341–8.
Szatkowski L, Vaz LR, Fiaschi L, Tata L, Coleman T. Trends in prescribing of nicotine replacement therapy to pregnant women in primary care in England. Nicotine Tob Res. 2021;23(9):1607–10.
Langley TE, Huang Y, McNeill A, Coleman T, Szatkowski L, Lewis S. Prescribing of smoking cessation medication in England since the introduction of varenicline. Addiction (Abingdon, England). 2011;106(7):1319–24.
Dhalwani NN, Tata LJ, Coleman T, Fleming KM, Szatkowski L. Completeness of Maternal Smoking Status Recording during Pregnancy in United Kingdom Primary Care Data. PLoS One. 2013;8(9):e72218.
Hardy B, Szatkowski L, Tata LJ, Coleman T, Dhalwani NN. Smoking cessation advice recorded during pregnancy in United Kingdom primary care. Szatkowski Lisa, Tata LJ, Coleman Tim, Dhalwani NN, editors. BMC Fam Pract. 2014;15:21.
Farley A, Koshiaris C, Oke J, Ryan R, Szatkowski L, Stevens R, et al. Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer. Ann Fam Med. 2017;15(5):443–50.
Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data. Br J Gen Pract. 2014;64(626):e554–60.
Tahrani AA, McCarthy M, Godson J, Taylor S, Slater H, Capps N, et al. Diabetes care and the new GMS contract: The evidence for a whole county. Br J Gen Pract. 2007;57(539):483–5.
McGovern MP, Boroujerdi MA, Taylor MW, Williams DJ, Hannaford PC, Lefevre KE, et al. The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care. Fam Pract. 2008;25(1):33–9.
Millett C, Gray J, Saxena S, Netuveli G, Majeed A. Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes. CMAJ. 2007;176(12):1705–10.
Fichera E, Gray E, Sutton M. How do individuals’ health behaviours respond to an increase in the supply of health care? Evidence from a natural experiment. Soc Sci Med. 2016;159:170–9.
Langley TE, McNeill A, Lewis S, Szatkowski L, Quinn C. The impact of media campaigns on smoking cessation activity: a structural vector autoregression analysis. Addiction (Abingdon, England). 2012;107(11):2043–50.
Sutton M, Elder R, Guthrie B, Watt G. Record rewards: the effects of targeted quality incentives on the recording of risk factors by primary care providers. Health Econ. 2010;19(1):1–13.
Forster AS, Burgess C, Dodhia H, Fuller F, Miller J, McDermott L, et al. Do health checks improve risk factor detection in primary care? Matched cohort study using electronic health records. J Public Health (Bangkok). 2016;38(3):552–9.
Simpson CR, Hannaford PC, Lefevre K, Williams D. Effect of the UK incentive-based contract on the management of patients with stroke in primary care. Stroke. 2006;37(9):2354–60.
Bailey S, Heintzman J, Marino M, Jacob R, Puro J, DeVoe J, et al. Smoking-Cessation Assistance: Before and After Stage 1 Meaningful Use Implementation. Am J Prev Med. 2017;53(2):192–200.
Mullins S, Fagan H, Reed J 3rd, Bercaw D. Ask and act: Delaware physicians demonstrate the effectiveness of the American Academy of Family Physicians’ initiative to promote tobacco cessation counseling. Del Med J. 2009;81(4):155–60.
Peterson LE, Blackburn B, Puffer JC, Phillips RL Jr. Family Physicians’ Quality Interventions and Performance Improvement for Hypertension through Maintenance of Certification. J Healthc Qual. 2016;38(3):175–86.
Thorndike AN, Regan S, Rigotti NA. The treatment of smoking by US physicians during ambulatory visits: 1994–2003. Am J Public Health. 2007;97(10):1878–83.
Bailey SR, Hoopes MJ, Marino M, Heintzman J, O’Malley JP, Hatch B, et al. Effect of Gaining Insurance Coverage on Smoking Cessation in Community Health Centers: A Cohort Study. J Gen Intern Med. 2016;31(10):1198–205.
Li J, Chung S, Martinez MC, Luft HS. Smoking-Cessation Interventions After Lung Cancer Screening Guideline Change. Am J Prev Med. 2020;59(1):88–97.
Fortmann SP, Bailey SR, Brooks NB, Hitsman B, Rittner SS, Gillespie SE, et al. Trends in smoking documentation rates in safety net clinics. Health Serv Res. 2020;55(2):170–7.
Miraldo M, Propper C, Williams RI. The impact of publicly subsidised health insurance on access, behavioural risk factors and disease management. Soc Sci Med. 2018;217:135–51.
Parnes B, Main DS, Holcomb S, Pace W. Tobacco cessation counseling among underserved patients: a report from CaReNet. J Fam Pract. 2002;51(1):65–9.
Shi L, Lee D, Chung M, Liang H, Lock D, Sripipatana A. Patient-Centered Medical Home Recognition and Clinical Performance in U.S. Community Health Centers. Health Serv Res. 2017;52(3):984–1004.
Bailey SR, Marino M, Ezekiel-Herrera D, Schmidt T, Angier H, Hoopes MJ, et al. Tobacco Cessation in Affordable Care Act Medicaid Expansion States Versus Non-expansion States. Nicotine Tob Res. 2020;22(6):1016.
Li J, Chung S, Wei EK, Luft HS. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low. BMC Health Serv Res. 2018;18(1):525.
Marino M, Bailey SR, Gold R, Hoopes MJ, O’Malley JP, Huguet N, et al. Receipt of Preventive Services After Oregon’s Randomized Medicaid Experiment. Am J Prev Med. 2016;50(2):161.
Tilson L, Bennett K, Barry M. Prescribing trends for nicotine replacement therapy in primary care. Ir Med J. 2004;97(9):270–3.
Williams D, Bennett K, Heery A, Feely J. Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban). Pharmacoepidemiol Drug Saf. 2004;13(6):411–5.
Bennett K, Jennings S, Collins C, Boland M, Leahy J, Bedford D, et al. Heartwatch: a secondary prevention programme in primary care in Ireland. Eur J Cardiovasc Prev Rehabil. 2008;15(6):651–6.
Fitzpatrick P, Fitz-Simon N, Lonergan M, Collins C, Daly L. Heartwatch: the effect of a primary care-delivered secondary prevention programme for cardiovascular disease on medication use and risk factor profiles. Eur J Cardiovasc Prev Rehabil. 2011;18(1):129–35.
Verbiest ME, Chavannes NH, Crone MR, Nielen MM, Segaar D, Korevaar JC, et al. An increase in primary care prescriptions of stop-smoking medication as a result of health insurance coverage in the Netherlands: population based study. Chavannes NH, Crone MR, Nielen MMJ, Segaar Dewi, editors. Addiction (Abingdon, England). 2013;108(12):2183–92.
van Doorn-Klomberg AL, Braspenning JCC, Wolters RJ, Bouma M, Wensing M. Effect of accreditation on the quality of chronic disease management: a comparative observational study. BMC Fam Pract. 2014;15:179.
Frijling B, Hulscher MEJL, van Leest LATM, Braspenning JCC, van den Hoogen H, Drenthen AJM, et al. Multifaceted support to improve preventive cardiovascular care: a nationwide, controlled trial in general practice. Br J Gen Pract. 2003;53(497):934–41.
Mullins R, Livingston P, Borland R. A strategy for involving general practitioners in smoking control. Aust N Z J Public Health. 1999;23(3):249–51.
Wright A, Cameron H, Roe Y, Lovett R. Analysing aggregate clinical data to support evaluation of the Tackling Indigenous Smoking program, 2014–16. Aust Health Rev. 2019;43(4):441–7.
Akman M, Sakarya S, Sargin M, Unluoglu I, Egici MT, Boerma WGW. Changes in primary care provision in Turkey: a comparison of 1993 and 2012. Health Policy. 2017;121(2):197–206.
Pajak A, Szafraniec K, Janion M, Szpak A, Wizner B, Wolfshaut-Wolak R, et al. The impact of the Polish national Programme of Cardiovascular Disease Prevention on the quality of primary cardiovascular disease prevention in clinical practice. Pajak A Janowski P, Kawalec E, Szafraniec K, Wolfshaut-Wolak R, Wizner B, Cichocka I, Drag P, Lasota P, Machnicka Z, Broda G, Drygas W, Gasior Z, Zdrojewski T, Steciwko A, Przybysz A, Panasiuk L, Paluch W, Drygas W, Bielecki W, Kwasniewska M, Pajak A, Br GT, editor. Kardiol Pol. 2010;68(12):1332–40.
Vasankari T, Pietinalho A, Lertola K, Junnila SY, Liippo K. Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme. BMC Fam Pract. 2011;12:97.
Donner-Banzhoff N, Kreienbrock L, Baum E. Family practitioners’ intervention against smoking in Germany and the UK: does remuneration affect preventive activity? Soz Praventivmed. 1996;41(4):224–30.
Royal College of Physicians. Smoking and health 2021: a coming of age for tobacco control? London; RCP; 2021.
Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger M. COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLoS Med. 2019;16(2):e1002742.
Royal Australian College of General Practitioners (RACGP). RACGP guideline: Supporting smoking cessation: A guide for health professionals. Chapter 2: Pharmacotherapy for smoking cessation. 2021. Available from: https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/supporting-smoking-cessation/pharmacotherapy-for-smoking-cessation. [Cited 2022 Mar 28].